Last 12 months
Inside the activity.
0 purchase rows · 54 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2019 Filed Mar 15, 2019 23:14 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 328 | $179.10 | $58,744.80 |
DisclosureSEC source: 0001225208-19-005379 · doc4.xml · nonDerivative · entry 3 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,974 F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse on August 29, 2018. Read SEC document |
| March 15, 2019 Filed Mar 15, 2019 23:14 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 774 | $179.10 | $138,623.40 |
DisclosureSEC source: 0001225208-19-005379 · doc4.xml · nonDerivative · entry 2 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,455.1517 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2018. Read SEC document |
| March 15, 2019 Filed Mar 15, 2019 23:14 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 372 | $179.10 | $66,625.20 |
DisclosureSEC source: 0001225208-19-005379 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,229.1517 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2018. Read SEC document |
| March 13, 2019 Filed Mar 13, 2019 21:16 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 5,500 | $0.00 Strike: $42.73 | $0.00 |
DisclosureSEC source: 0001225208-19-005217 · doc4.xml · derivative · entry 6 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Common Stock · 5,500 shares Expires 2019-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2018. Read SEC document |
| March 13, 2019 Filed Mar 13, 2019 21:16 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 5,500 | $175.73 | $966,515.00 |
DisclosureSEC source: 0001225208-19-005217 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,982.2297 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2018. Read SEC document |
| March 13, 2019 Filed Mar 13, 2019 21:16 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionCommon Stock | 5,500 | $42.73 | $234,987.50 |
DisclosureSEC source: 0001225208-19-005217 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,482.2297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2018. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 18:21 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 8,800 | $0.00 Strike: $35.79 | $0.00 |
DisclosureSEC source: 0001225208-19-004992 · doc4.xml · derivative · entry 9 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,800 Underlying: Common Stock · 8,800 shares Expires 2020-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2018. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 18:21 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 24,000 | $0.00 Strike: $42.73 | $0.00 |
DisclosureSEC source: 0001225208-19-004992 · doc4.xml · derivative · entry 8 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2019-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2018. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 18:21 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 20,261 | $168.03 | $3,404,354.53 |
DisclosureSEC source: 0001225208-19-004992 · doc4.xml · nonDerivative · entry 5 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,125.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2018. F4 · price: This transaction was executed in multiple trades at prices ranging from $167.5500 to $168.5350. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 18:21 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 9,095 | $167.24 | $1,521,089.64 |
DisclosureSEC source: 0001225208-19-004992 · doc4.xml · nonDerivative · entry 4 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,386.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2018. F3 · price: This transaction was executed in multiple trades at prices ranging from $166.5500 to $167.5400. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 18:21 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 3,444 | $168.80 | $581,337.21 |
DisclosureSEC source: 0001225208-19-004992 · doc4.xml · nonDerivative · entry 3 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,481.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $168.5500 to $169.2400. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 18:21 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 8,800 | $35.79 | $314,908.00 |
DisclosureSEC source: 0001225208-19-004992 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,925.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2018. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 18:21 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 24,000 | $42.73 | $1,025,400.00 |
DisclosureSEC source: 0001225208-19-004992 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,125.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2018. Read SEC document |
| March 01, 2019 Filed Mar 2, 2019 00:02 UTC |
Wood Larry LCVP, TAVR
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 6,716 | $0.00 Strike: $41.94 | $0.00 |
DisclosureSEC source: 0001225208-19-004205 · doc4.xml · derivative · entry 4 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,452 Underlying: Common Stock · 6,716 shares Expires 2021-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2018. Read SEC document |
| March 01, 2019 Filed Mar 2, 2019 00:02 UTC |
Wood Larry LCVP, TAVR
|
SaleCommon Stock | 6,716 | $170.82 | $1,147,227.12 |
DisclosureSEC source: 0001225208-19-004205 · doc4.xml · nonDerivative · entry 2 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,649.8685 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2018. Read SEC document |
| March 01, 2019 Filed Mar 2, 2019 00:02 UTC |
Wood Larry LCVP, TAVR
|
Exercise / conversionCommon Stock | 6,716 | $41.94 | $281,669.04 |
DisclosureSEC source: 0001225208-19-004205 · doc4.xml · nonDerivative · entry 1 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,365.8685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2018. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 00:09 UTC |
SELLERS ROBERT W.A.VP, Corporate Controller
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 500 | $0.00 Strike: $35.79 | $0.00 |
DisclosureSEC source: 0001225208-19-003457 · doc4.xml · derivative · entry 3 SELLERS ROBERT W.A. · CIK 0001600739 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,297 Underlying: Common Stock · 500 shares Expires 2020-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 00:09 UTC |
SELLERS ROBERT W.A.VP, Corporate Controller
|
SaleCommon Stock | 500 | $175.04 | $87,519.35 |
DisclosureSEC source: 0001225208-19-003457 · doc4.xml · nonDerivative · entry 2 SELLERS ROBERT W.A. · CIK 0001600739 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,281.5648 F1 · price: This transaction was executed in multiple trades at prices ranging from $175.03 to $175.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 00:09 UTC |
SELLERS ROBERT W.A.VP, Corporate Controller
|
Exercise / conversionCommon Stock | 500 | $35.79 | $17,892.50 |
DisclosureSEC source: 0001225208-19-003457 · doc4.xml · nonDerivative · entry 1 SELLERS ROBERT W.A. · CIK 0001600739 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,781.5648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2019 Filed Feb 22, 2019 02:39 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 328 | $176.34 | $57,839.52 |
DisclosureSEC source: 0001225208-19-003318 · doc4.xml · nonDerivative · entry 3 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2,302 F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's husband on August 29, 2018. Read SEC document |
| February 21, 2019 Filed Feb 22, 2019 02:39 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 774 | $176.34 | $136,487.16 |
DisclosureSEC source: 0001225208-19-003318 · doc4.xml · nonDerivative · entry 2 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,601.1517 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2018. Read SEC document |
| February 21, 2019 Filed Feb 22, 2019 02:39 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 372 | $176.34 | $65,598.48 |
DisclosureSEC source: 0001225208-19-003318 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,375.1517 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2018. Read SEC document |
| February 21, 2019 Filed Feb 22, 2019 02:39 UTC |
SELLERS ROBERT W.A.VP, Corporate Controller
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 2,623 | $0.00 Strike: $35.79 | $0.00 |
DisclosureSEC source: 0001225208-19-003317 · doc4.xml · derivative · entry 3 SELLERS ROBERT W.A. · CIK 0001600739 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,797 Underlying: Common Stock · 2,623 shares Expires 2020-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2019 Filed Feb 22, 2019 02:39 UTC |
SELLERS ROBERT W.A.VP, Corporate Controller
|
SaleCommon Stock | 2,623 | $175.08 | $459,223.30 |
DisclosureSEC source: 0001225208-19-003317 · doc4.xml · nonDerivative · entry 2 SELLERS ROBERT W.A. · CIK 0001600739 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,281.5648 F1 · price: This transaction was executed in multiple trades at prices ranging from $175.03 to $175.12. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 21, 2019 Filed Feb 22, 2019 02:39 UTC |
SELLERS ROBERT W.A.VP, Corporate Controller
|
Exercise / conversionCommon Stock | 2,623 | $35.79 | $93,864.06 |
DisclosureSEC source: 0001225208-19-003317 · doc4.xml · nonDerivative · entry 1 SELLERS ROBERT W.A. · CIK 0001600739 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,904.5648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2019 Filed Feb 27, 2019 01:04 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
GrantCommon Stock | 575 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-003784 · doc4.xml · nonDerivative · entry 1 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,376 F1 · shares: These restricted stock units were granted on February 21, 2019 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become 50% vested three years after the grant date and 50% vested four years after the grant date. Read SEC document |
| February 19, 2019 Filed Feb 20, 2019 01:31 UTC |
Szyman Catherine M.CVP, Critical Care
|
Tax withholdingCommon Stock | 2,227 | $177.78 | $395,916.06 |
DisclosureSEC source: 0001225208-19-003009 · doc4.xml · nonDerivative · entry 2 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,747.1517 Read SEC document |
| February 19, 2019 Filed Feb 20, 2019 01:31 UTC |
Szyman Catherine M.CVP, Critical Care
|
Tax withholdingCommon Stock | 697 | $177.78 | $123,912.66 |
DisclosureSEC source: 0001225208-19-003009 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,974.1517 Read SEC document |
| February 13, 2019 Filed Feb 13, 2019 22:20 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 5,500 | $0.00 Strike: $42.73 | $0.00 |
DisclosureSEC source: 0001225208-19-002460 · doc4.xml · derivative · entry 6 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,100 Underlying: Common Stock · 5,500 shares Expires 2019-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2018. Read SEC document |
| February 13, 2019 Filed Feb 13, 2019 22:20 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 5,500 | $177.75 | $977,625.00 |
DisclosureSEC source: 0001225208-19-002460 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,982.2297 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2018. Read SEC document |
| February 13, 2019 Filed Feb 13, 2019 22:20 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionCommon Stock | 5,500 | $42.73 | $234,987.50 |
DisclosureSEC source: 0001225208-19-002460 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,482.2297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2018. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 02:38 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 32,800 | $0.00 Strike: $42.73 | $0.00 |
DisclosureSEC source: 0001225208-19-002359 · doc4.xml · derivative · entry 9 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 32,800 shares Expires 2019-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2018. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 02:38 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 14,898 | $177.91 | $2,650,485.30 |
DisclosureSEC source: 0001225208-19-002359 · doc4.xml · nonDerivative · entry 6 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,125.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2018. F6 · price: This transaction was executed in multiple trades at prices ranging from $177.40 to $178.31. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 02:38 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 10,702 | $177.05 | $1,894,769.84 |
DisclosureSEC source: 0001225208-19-002359 · doc4.xml · nonDerivative · entry 5 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,023.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2018. F5 · price: This transaction was executed in multiple trades at prices ranging from $176.3750 to $177.36. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 02:38 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 3,050 | $173.75 | $529,927.74 |
DisclosureSEC source: 0001225208-19-002359 · doc4.xml · nonDerivative · entry 4 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,725.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2018. F4 · price: This transaction was executed in multiple trades at prices ranging from $173.33 to $174.31. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 02:38 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 2,400 | $175.65 | $421,564.80 |
DisclosureSEC source: 0001225208-19-002359 · doc4.xml · nonDerivative · entry 3 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,775.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2018. F3 · price: This transaction was executed in multiple trades at prices ranging from $175.37 to $176.34. The price reported above reflects the weighted average sale price. The Reporting person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 02:38 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 1,750 | $174.65 | $305,646.08 |
DisclosureSEC source: 0001225208-19-002359 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,175.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $174.35 to $175.26. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 02:38 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 32,800 | $42.73 | $1,401,380.00 |
DisclosureSEC source: 0001225208-19-002359 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,925.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2018. Read SEC document |
| February 05, 2019 Filed Feb 5, 2019 22:27 UTC |
WANG HUIMINCVP, Japan & Intercontinental
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 4,000 | $0.00 Strike: $42.73 | $0.00 |
DisclosureSEC source: 0001225208-19-001828 · doc4.xml · derivative · entry 3 WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2019-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2018. Read SEC document |
| February 05, 2019 Filed Feb 5, 2019 22:27 UTC |
WANG HUIMINCVP, Japan & Intercontinental
|
SaleCommon Stock | 4,000 | $171.68 | $686,720.00 |
DisclosureSEC source: 0001225208-19-001828 · doc4.xml · nonDerivative · entry 2 WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,224.3906 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2018. Read SEC document |
| February 05, 2019 Filed Feb 5, 2019 22:27 UTC |
WANG HUIMINCVP, Japan & Intercontinental
|
Exercise / conversionCommon Stock | 4,000 | $42.73 | $170,900.00 |
DisclosureSEC source: 0001225208-19-001828 · doc4.xml · nonDerivative · entry 1 WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,224.3906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2018. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 11:01 UTC |
Wood Larry LCVP, THV Replacement
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 6,716 | $0.00 Strike: $41.94 | $0.00 |
DisclosureSEC source: 0001225208-19-001757 · doc4.xml · derivative · entry 4 Wood Larry L · CIK 0001440660 · CVP, THV Replacement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,168 Underlying: Common Stock · 6,716 shares Expires 2021-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2018. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 11:01 UTC |
Wood Larry LCVP, THV Replacement
|
SaleCommon Stock | 6,716 | $169.10 | $1,135,675.60 |
DisclosureSEC source: 0001225208-19-001757 · doc4.xml · nonDerivative · entry 2 Wood Larry L · CIK 0001440660 · CVP, THV Replacement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,649.8685 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2018. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 11:01 UTC |
Wood Larry LCVP, THV Replacement
|
Exercise / conversionCommon Stock | 6,716 | $41.94 | $281,669.04 |
DisclosureSEC source: 0001225208-19-001757 · doc4.xml · nonDerivative · entry 1 Wood Larry L · CIK 0001440660 · CVP, THV Replacement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,365.8685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2018. Read SEC document |
| January 16, 2019 Filed Jan 17, 2019 02:05 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 5,500 | $0.00 Strike: $42.73 | $0.00 |
DisclosureSEC source: 0001225208-19-000913 · doc4.xml · derivative · entry 6 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,600 Underlying: Common Stock · 5,500 shares Expires 2019-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2018. Read SEC document |
| January 16, 2019 Filed Jan 17, 2019 02:05 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 5,500 | $162.03 | $891,165.00 |
DisclosureSEC source: 0001225208-19-000913 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,982.2297 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2018. Read SEC document |
| January 16, 2019 Filed Jan 17, 2019 02:05 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionCommon Stock | 5,500 | $42.73 | $234,987.50 |
DisclosureSEC source: 0001225208-19-000913 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,482.2297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2018. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 02:05 UTC |
Szyman Catherine M.CVP, Critical Care & Vascular
|
SaleCommon Stock | 328 | $155.00 | $50,840.00 |
DisclosureSEC source: 0001225208-19-000914 · doc4.xml · nonDerivative · entry 2 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care & Vascular 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2,630 F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's husband on August 29, 2018. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 02:05 UTC |
Szyman Catherine M.CVP, Critical Care & Vascular
|
SaleCommon Stock | 372 | $155.00 | $57,660.00 |
DisclosureSEC source: 0001225208-19-000914 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care & Vascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,671.1517 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2018. F2 · balance_after: This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator. Read SEC document |
| January 07, 2019 Filed Jan 7, 2019 22:57 UTC |
Wood Larry LCVP, THV Replacement
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 6,716 | $0.00 Strike: $41.94 | $0.00 |
DisclosureSEC source: 0001225208-19-000698 · doc4.xml · derivative · entry 4 Wood Larry L · CIK 0001440660 · CVP, THV Replacement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,884 Underlying: Common Stock · 6,716 shares Expires 2021-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.